Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Infection01:20

Infection

8.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.7K
Stages of Infection01:26

Stages of Infection

58.9K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
58.9K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

43
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
43
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

26
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
26
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

410
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
410
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.4K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

Responding Appropriately to Safety Signals in Infants Exposed to the 6-month BDLLfx/BDLCfz Regimen In Utero.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

The Lancet. Infectious diseases·2026
Same author

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

"Six months is a lot of time to lie": Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial.

Research square·2026
Same author

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

The Lancet. Infectious diseases·2025

関連する実験動画

Updated: Sep 8, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.4K

"致命 的 な 感染"

Jennifer Furin1

  • 1Division of Infectious Diseases, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
|August 20, 2025
PubMed
まとめ
この要約は機械生成です。

抗菌剤耐性 (AMR) は,特に複雑な感染症の患者ケアに大きな影響を及ぼします. この反省は,感染性疾患 (ID) の提供者にとって,困難な抗菌剤耐性症例を効果的に管理するための協力的戦略を探求しています.

キーワード:
抗生物質抗菌剤耐性協力する入院患者緩和ケア

さらに関連する動画

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

528
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.6K

関連する実験動画

Last Updated: Sep 8, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.4K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

528
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.6K

科学分野:

  • 臨床医学
  • 感染症
  • 微生物学

背景:

  • 抗菌剤耐性 (AMR) は,世界的な健康と患者のアウトカムに重大な脅威をもたらしています.
  • AMR患者の複雑な感染症の管理は,医療従事者にとって大きな課題です.
  • 現在の臨床実践では,抗菌剤耐性の増加と闘うための強化された戦略が必要である.

研究 の 目的:

  • 抗菌剤耐性 (AMR) に関する臨床経験について考える.
  • 複雑な感染症の管理のための潜在的な協力的アプローチを特定し,提案する.
  • AMRに罹患した患者の臨床管理を強化する.

主な方法:

  • AMRとの臨床接触の遡及的分析
  • 感染症 (ID) 提供者が直面する課題に関する質的思考
  • 分野間の協力モデルの探求

主要な成果:

  • AMRによる複雑な感染症は,多面的な管理戦略を必要とします.
  • 医療従事者の協力により 患者の治療成果が向上します
  • 効果的な抗菌剤耐性管理には 具体的な協力的なアプローチを 特定することが重要です

結論:

  • 抗生物質耐性を効果的に管理するには,ID提供者と他の専門家の共同アプローチが必要です.
  • 抗生物質耐性対策には 協力モデルに関するさらなる研究と実施が不可欠です
  • 抗生物質耐性に対処するには,臨床環境内で統一された戦略的な取り組みが必要です.